Market Overview

D.A. Davidson Reiterates Buy Rating on Herbalife Ltd. as Short-Covering Begins

Related HLF
Barclays Cuts Herbalife Price Target, Addresses Debt Concerns
UPDATE: BTIG Research Initiates Coverage On Herbalife On Significant Upside Potential
Global Jitters Send Wall Street Tumbling (Fox Business)

In a report published Friday, D.A. Davidson analyst Timothy S. Ramey reiterated a Buy rating and $78.00 price target on Herbalife (NYSE: HLF).

In the report, D.A. Davidson noted, “Herbalife's short interest, which peaked at 37.2 million shares on December 31st (at a price of $32.94), fell recently to a still-huge 31 million shares on May 31st, down from 33 million shares on May 15th. The shorts have been buried in this position since the start of the year, with the stock up $12.50 plus $0.60 in dividends for a total return, year-to-date of 40%. That is before the 2.75% cost to borrow the stock. The short thesis has been thoroughly discredited and even on a day such as today, when a congresswoman asks the FTC to investigate Herbalife as a pyramid scheme, the shares are up.”

Herbalife closed on Thursday at $46.86.

Latest Ratings for HLF

DateFirmActionFromTo
Nov 2014BarclaysMaintainsOverweight
Nov 2014BTIG ResearchInitiates Coverage onBuy
Nov 2014SunTrust Robinson HumphreyDowngradesBuyNeutral

View More Analyst Ratings for HLF
View the Latest Analyst Ratings

Posted-In: D.A. Davidson Timothy S. RameyAnalyst Color Reiteration Analyst Ratings

 

Related Articles (HLF)

Around the Web, We're Loving...

Get Benzinga's Newsletters